These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31819792)

  • 1. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Lassa virus among rodents trapped in three South-South States of Nigeria.
    Agbonlahor DE; Erah A; Agba IM; Oviasogie FE; Ehiaghe AF; Wankasi M; Eremwanarue OA; Ehiaghe IJ; Ogbu EC; Iyen RI; Abbey S; Tatfeng MY; Uhunmwangho J
    J Vector Borne Dis; 2017; 54(2):146-150. PubMed ID: 28748835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.
    Asogun DA; Adomeh DI; Ehimuan J; Odia I; Hass M; Gabriel M; Olschläger S; Becker-Ziaja B; Folarin O; Phelan E; Ehiane PE; Ifeh VE; Uyigue EA; Oladapo YT; Muoebonam EB; Osunde O; Dongo A; Okokhere PO; Okogbenin SA; Momoh M; Alikah SO; Akhuemokhan OC; Imomeh P; Odike MA; Gire S; Andersen K; Sabeti PC; Happi CT; Akpede GO; Günther S
    PLoS Negl Trop Dis; 2012; 6(9):e1839. PubMed ID: 23029594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study.
    Duvignaud A; Jaspard M; Etafo IC; Gabillard D; Serra B; Abejegah C; le Gal C; Abidoye AT; Doutchi M; Owhin S; Séri B; Vihundira JK; Bérerd-Camara M; Schaeffer J; Danet N; Augier A; Ogbaini-Emovon E; Salam AP; Ahmed LA; Duraffour S; Horby P; Günther S; Adedosu AN; Ayodeji OO; Anglaret X; Malvy D;
    Lancet Glob Health; 2021 Apr; 9(4):e469-e478. PubMed ID: 33740408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.
    Salu OB; Akinbamiro TF; Orenolu RM; Ishaya OD; Anyanwu RA; Vitowanu OR; Abdullah MA; Olowoyeye AH; Tijani SO; Oyedeji KS; Omilabu SA
    PLoS One; 2024; 19(6):e0305521. PubMed ID: 38905317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study.
    Tiamiyu AB; Adegbite OA; Freides O; Frndak S; Mohammed SS; Broach E; Lombardi K; Anyebe V; Akiga R; Okeke NC; Feyisayo JE; Ugwuezumba O; Akinde C; Osuji A; Agu N; Analogbei T; Ekweremadu C; Bartolanzo D; Prins P; Fan Y; Emekaili D; Abah F; Chiwetelu V; Dike P; Isaiah E; Ayogu M; Ogunkelu E; Agbaim UC; Bukunmi A; Adamu Y; Mebrahtu T; Zuppe A; Johnston M; Modjarrad K; Meri H; Parker Z; Akinwale E; McCauley MD; Schluck G; King DB; Eller LA; Okeji N; Ayemoba OR; Collins ND; Iroezindu MO; Hakre S;
    BMC Infect Dis; 2024 Oct; 24(1):1118. PubMed ID: 39375602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area.
    Akhuemokhan OC; Ewah-Odiase RO; Akpede N; Ehimuan J; Adomeh DI; Odia I; Olomu SC; Pahlmann M; Becker-Ziaja B; Happi CT; Asogun DA; Okogbenin SA; Okokhere PO; Dawodu OS; Omoike IU; Sabeti PC; Günther S; Akpede GO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005711. PubMed ID: 28671959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.
    Olschläger S; Lelke M; Emmerich P; Panning M; Drosten C; Hass M; Asogun D; Ehichioya D; Omilabu S; Günther S
    J Clin Microbiol; 2010 Jun; 48(6):2009-13. PubMed ID: 20351210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005-2008.
    Ehichioya DU; Asogun DA; Ehimuan J; Okokhere PO; Pahlmann M; Olschläger S; Becker-Ziaja B; Günther S; Omilabu SA
    Trop Med Int Health; 2012 Aug; 17(8):1001-4. PubMed ID: 22594713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.
    Happi AN; Olumade TJ; Ogunsanya OA; Sijuwola AE; Ogunleye SC; Oguzie JU; Nwofoke C; Ugwu CA; Okoro SJ; Otuh PI; Ngele LN; Ojo OO; Adelabu A; Adeleye RF; Oyejide NE; Njaka CS; Heeney JL; Happi CT
    Microbiol Spectr; 2022 Aug; 10(4):e0036622. PubMed ID: 35913205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lassa fever, Nigeria, 2003 and 2004.
    Omilabu SA; Badaru SO; Okokhere P; Asogun D; Drosten C; Emmerich P; Becker-Ziaja B; Schmitz H; Günther S
    Emerg Infect Dis; 2005 Oct; 11(10):1642-4. PubMed ID: 16355508
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
    Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an RT-LAMP assay for the detection of Lassa viruses in southeast and south-central Nigeria.
    Pemba CM; Kurosaki Y; Yoshikawa R; Oloniniyi OK; Urata S; Sueyoshi M; Zadeh VR; Nwafor I; Iroezindu MO; Ajayi NA; Chukwubike CM; Chika-Igwenyi NM; Ndu AC; Nwidi DU; Maehira Y; Unigwe US; Ojide CK; Onwe EO; Yasuda J
    J Virol Methods; 2019 Jul; 269():30-37. PubMed ID: 30974179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in Lassa Fever Cases in Nigeria, January-March 2018.
    Ilori EA; Frank C; Dan-Nwafor CC; Ipadeola O; Krings A; Ukponu W; Womi-Eteng OE; Adeyemo A; Mutbam SK; Musa EO; Lasuba CLP; Alemu W; Okogbenin S; Ogbaini E; Unigwe U; Ogah E; Onoh R; Abejegah C; Ayodeji O; Ihekweazu C
    Emerg Infect Dis; 2019 May; 25(5):1026-1027. PubMed ID: 30807268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study.
    Elsinga J; Sunyoto T; di Stefano L; Giorgetti PF; Kyi HA; Burzio C; Campos Moreno X; Ojide CK; Ajayi N; Ewah R; Ogah EO; Dan-Nwafor C; Ahumibe A; Ochu CL; Olayinka A; Jonckheere S; Chaillet P; van Herp M
    Lancet Infect Dis; 2024 Sep; 24(9):1037-1044. PubMed ID: 38734012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.